| Effects of different sweet preloads on incretin hormone secretion, gastric emptying, and postprandial glycemia in healthy humans T Wu, BR Zhao, MJ Bound, HL Checklin, M Bellon, TJ Little, RL Young, ... The American journal of clinical nutrition 95 (1), 78-83, 2012 | 186 | 2012 |
| Effects of rectal administration of taurocholic acid on glucagon‐like peptide‐1 and peptide YY secretion in healthy humans T Wu, MJ Bound, SD Standfield, B Gedulin, KL Jones, M Horowitz, ... Diabetes, Obesity and Metabolism 15 (5), 474-477, 2013 | 142 | 2013 |
| Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trial SS Thazhath, T Wu, MJ Bound, HL Checklin, S Standfield, KL Jones, ... The American journal of clinical nutrition 103 (1), 66-70, 2016 | 130 | 2016 |
| Disordered control of intestinal sweet taste receptor expression and glucose absorption in type 2 diabetes RL Young, B Chia, NJ Isaacs, J Ma, J Khoo, T Wu, M Horowitz, CK Rayner Diabetes 62 (10), 3532-3541, 2013 | 130 | 2013 |
| Gut motility and enteroendocrine secretion T Wu, CK Rayner, RL Young, M Horowitz Current Opinion in Pharmacology 13 (6), 928-934, 2013 | 119 | 2013 |
| Whey protein: The “whey” forward for treatment of type 2 diabetes? LE Mignone, T Wu, M Horowitz, CK Rayner World journal of diabetes 6 (14), 1274, 2015 | 107 | 2015 |
| A protein preload enhances the glucose-lowering efficacy of vildagliptin in type 2 diabetes T Wu, TJ Little, MJ Bound, M Borg, X Zhang, CF Deacon, M Horowitz, ... Diabetes Care 39 (4), 511-517, 2016 | 104 | 2016 |
| Role of bile acids in the regulation of food intake, and their dysregulation in metabolic disease C Xie, W Huang, RL Young, KL Jones, M Horowitz, CK Rayner, T Wu Nutrients 13 (4), 1104, 2021 | 96 | 2021 |
| Mechanism of glucose‐lowering by metformin in type 2 diabetes: role of bile acids DJ Sansome, C Xie, S Veedfald, M Horowitz, CK Rayner, T Wu Diabetes, Obesity and Metabolism 22 (2), 141-148, 2020 | 95 | 2020 |
| Gastric emptying in patients with well-controlled type 2 diabetes compared with young and older control subjects without diabetes LE Watson, C Xie, X Wang, Z Li, LK Phillips, Z Sun, KL Jones, M Horowitz, ... The Journal of Clinical Endocrinology & Metabolism 104 (8), 3311-3319, 2019 | 94 | 2019 |
| Augmented capacity for peripheral serotonin release in human obesity RL Young, AL Lumsden, AM Martin, G Schober, N Pezos, SS Thazhath, ... International Journal of Obesity 42 (11), 1880-1889, 2018 | 92 | 2018 |
| Mechanism of increase in plasma intact GLP-1 by metformin in type 2 diabetes: stimulation of GLP-1 secretion or reduction in plasma DPP-4 activity? T Wu, SS Thazhath, MJ Bound, KL Jones, M Horowitz, CK Rayner Diabetes research and clinical practice 106 (1), e3-e6, 2014 | 90 | 2014 |
| Effects of taurocholic acid on glycemic, glucagon-like peptide-1, and insulin responses to small intestinal glucose infusion in healthy humans T Wu, MJ Bound, SD Standfield, KL Jones, M Horowitz, CK Rayner The Journal of Clinical Endocrinology & Metabolism 98 (4), E718-E722, 2013 | 90 | 2013 |
| The glucagon-like peptide 1 receptor agonist exenatide inhibits small intestinal motility, flow, transit, and absorption of glucose in healthy subjects and patients with type 2 … SS Thazhath, CS Marathe, T Wu, J Chang, J Khoo, P Kuo, HL Checklin, ... Diabetes 65 (1), 269-275, 2016 | 83 | 2016 |
| Metformin reduces the rate of small intestinal glucose absorption in type 2 diabetes T Wu, C Xie, H Wu, KL Jones, M Horowitz, CK Rayner Diabetes, Obesity and Metabolism 19 (2), 290-293, 2017 | 77 | 2017 |
| Artificial sweeteners have no effect on gastric emptying, glucagon-like peptide-1, or glycemia after oral glucose in healthy humans T Wu, MJ Bound, SD Standfield, M Bellon, RL Young, KL Jones, ... Diabetes care 36 (12), e202-e203, 2013 | 73 | 2013 |
| New insights into the anti-diabetic actions of metformin: from the liver to the gut T Wu, M Horowitz, CK Rayner Expert review of gastroenterology & hepatology 11 (2), 157-166, 2017 | 70 | 2017 |
| Incretins T Wu, CK Rayner, M Horowitz Metabolic control, 137-171, 2016 | 70 | 2016 |
| Role of intestinal bitter sensing in enteroendocrine hormone secretion and metabolic control C Xie, X Wang, RL Young, M Horowitz, CK Rayner, T Wu Frontiers in endocrinology 9, 576, 2018 | 67 | 2018 |
| Exenatide once weekly slows gastric emptying of solids and liquids in healthy, overweight people at steady‐state concentrations KL Jones, LQ Huynh, S Hatzinikolas, RS Rigda, LK Phillips, HT Pham, ... Diabetes, Obesity and Metabolism 22 (5), 788-797, 2020 | 64 | 2020 |
Rayner, C.K.University of AdelaidePotvrđena adresa e-pošte na adelaide.edu.au
